SMS Lifesciences [SMSLIFE] vs Panacea Biotec [PANACEABIO] Detailed Stock Comparison

SMS Lifesciences

NSE
Loading...

Panacea Biotec

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: SMS Lifesciences wins in 12 metrics, Panacea Biotec wins in 6 metrics, with 0 ties. SMS Lifesciences appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricSMS LifesciencesPanacea BiotecBetter
P/E Ratio (TTM)19.42217.01SMS Lifesciences
Price-to-Book Ratio1.712.96SMS Lifesciences
Debt-to-Equity Ratio40.752.67Panacea Biotec
PEG Ratio-0.48-1.73Panacea Biotec
EV/EBITDA10.77-181.19Panacea Biotec
Profit Margin (TTM)5.17%1.88%SMS Lifesciences
Operating Margin (TTM)9.56%-5.74%SMS Lifesciences
EBITDA Margin (TTM)9.56%N/AN/A
Return on Equity9.48%-1.01%SMS Lifesciences
Return on Assets (TTM)5.16%-0.65%SMS Lifesciences
Free Cash Flow (TTM)$187.06M$-776.80MSMS Lifesciences
Dividend Yield0.13%N/AN/A
1-Year Return-27.81%27.50%Panacea Biotec
Price-to-Sales Ratio (TTM)1.004.08SMS Lifesciences
Enterprise Value$4.36B$23.98BPanacea Biotec
EV/Revenue Ratio1.303.93SMS Lifesciences
Gross Profit Margin (TTM)37.40%53.68%Panacea Biotec
Revenue per Share (TTM)$1,107$100SMS Lifesciences
Earnings per Share (Diluted)$57.24$1.87SMS Lifesciences
Beta (Stock Volatility)0.220.36SMS Lifesciences
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

SMS Lifesciences vs Panacea Biotec Stock Performance Analysis

Loading Price Chart...

SMS Lifesciences
Panacea Biotec
SMS Lifesciences Stock Overview | Panacea Biotec Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
SMS Lifesciences-0.12%1.42%2.44%-7.60%7.14%-2.88%
Panacea Biotec3.42%-2.44%-0.84%-10.09%4.76%-7.62%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
SMS Lifesciences-27.81%68.60%84.29%723.03%723.03%723.03%
Panacea Biotec27.50%195.84%130.28%205.43%102.14%53.20%

News Based Sentiment: SMS Lifesciences vs Panacea Biotec

SMS Lifesciences

News based Sentiment: NEGATIVE

The month was marked by declining profitability despite revenue growth, coupled with a strategic name change and upcoming AGM. These developments signal potential challenges and a shift in direction for the company, making it a significant period for investors to assess the investment case.

View SMS Lifesciences News Sentiment Analysis

Panacea Biotec

News based Sentiment: MIXED

Panacea Biotec experienced a significant financial turnaround in Q1 FY2026, securing a major contract with UNICEF and expanding its R&D pipeline. However, bearish analyst sentiment and shifts in institutional holdings create a mixed investment picture, making this a moderately important month for investors.

View Panacea Biotec News Sentiment Analysis

Performance & Financial Health Analysis: SMS Lifesciences vs Panacea Biotec

MetricSMSLIFEPANACEABIO
Market Information
Market Cap i₹3.37B₹25.60B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i881237,434
90 Day Avg. Volume i2,883213,962
Last Close₹1,163.60₹419.15
52 Week Range₹959.80 - ₹1,749.65₹244.00 - ₹581.90
% from 52W High-33.50%-27.97%
All-Time High₹1,749.65 (Sep 09, 2024)₹581.90 (Apr 28, 2025)
% from All-Time High-33.50%-27.97%
Growth Metrics
Quarterly Revenue Growth-0.11%0.44%
Quarterly Earnings Growth-0.41%0.44%
Financial Health
Profit Margin (TTM) i0.05%0.02%
Operating Margin (TTM) i0.10%-0.06%
Return on Equity (TTM) i0.09%-0.01%
Debt to Equity (MRQ) i40.752.67
Cash & Liquidity
Book Value per Share (MRQ)₹649.96₹136.92
Cash per Share (MRQ)₹4.99₹17.95
Operating Cash Flow (TTM) i₹289.74M₹-1,547,900,000
Levered Free Cash Flow (TTM) i₹201.09M₹-83,700,000
Dividends
Last 12-Month Dividend Yield i0.13%N/A
Last 12-Month Dividend i₹1.50₹0.00

Valuation & Enterprise Metrics Analysis: SMS Lifesciences vs Panacea Biotec

MetricSMSLIFEPANACEABIO
Price Ratios
P/E Ratio (TTM) i19.42217.01
Forward P/E iN/AN/A
PEG Ratio i-0.48-1.73
Price to Sales (TTM) i1.004.08
Price to Book (MRQ) i1.712.96
Market Capitalization
Market Capitalization i₹3.37B₹25.60B
Enterprise Value i₹4.36B₹23.98B
Enterprise Value Metrics
Enterprise to Revenue i1.303.93
Enterprise to EBITDA i10.77-181.19
Risk & Other Metrics
Beta i0.220.36
Book Value per Share (MRQ) i₹649.96₹136.92

Financial Statements Comparison: SMS Lifesciences vs Panacea Biotec

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SMSLIFEPANACEABIO
Revenue/Sales i₹891.12M₹1.33B
Cost of Goods Sold i₹563.17M₹520.80M
Gross Profit i₹327.95M₹804.50M
Research & Development iN/AN/A
Operating Income (EBIT) i₹36.23M₹-353.00M
EBITDA i₹97.61M₹-182.90M
Pre-Tax Income i₹39.29M₹-400,000
Income Tax i₹4.46M₹19.50M
Net Income (Profit) i₹34.83M₹-19.90M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SMSLIFEPANACEABIO
Cash & Equivalents i₹5.03M₹821.30M
Total Current Assets i₹1.51B₹5.45B
Total Current Liabilities i₹1.42B₹3.67B
Long-Term Debt i₹200.07M₹222.10M
Total Shareholders Equity i₹2.12B₹8.31B
Retained Earnings iN/AN/A
Property, Plant & Equipment i₹2.32B₹5.43B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SMSLIFEPANACEABIO
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSMSLIFEPANACEABIO
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i881237,434
Average Daily Volume (90 Day) i2,883213,962
Shares Outstanding i3.02M61.25M
Float Shares i645,66515.45M
% Held by Insiders i0.74%0.73%
% Held by Institutions i0.00%0.00%

Dividend Analysis & Yield Comparison: SMS Lifesciences vs Panacea Biotec

MetricSMSLIFEPANACEABIO
Last 12-Month Dividend i₹1.50₹0.00
Last 12-Month Dividend Yield i0.13%N/A
3-Year Avg Annual Dividend i₹1.50₹0.00
3-Year Avg Dividend Yield i0.20%N/A
3-Year Total Dividends i₹4.50₹0.00
Ex-Dividend DateSep 23, 2024N/A